Back to Results
First PageMeta Content
Medicine / Clinical research / Sun tanning / Pharmaceutical industry / Design of experiments / Sunscreen / Adverse event / Sunburn / Ultraviolet / Electromagnetic radiation / Health / Pharmacology


Clinical Review Joseph M. Porres MD, PhD NDA 22009, N-000 Helioblock-SX
Add to Reading List

Open Document

File Size: 3,90 MB

Share Result on Facebook

Company

AEs / Oreal / /

Country

United States / Canada / /

Currency

MOP / PEN / /

Event

FDA Phase / /

Facility

Laboratory Findings / /

IndustryTerm

ecamsule-containing sunscreen drug products / study products / manufacturing / /

MedicalCondition

acne / skin infection / Photosensitization / dermatitis / Phototoxicity / eczema / erythema / PFA / photoallergy / local skin irritation / sunburn / irritation / pruritus / /

Organization

European Union / Advisory Committee / /

Person

Joseph M. Porres / Daiva Shetty / /

Position

investigator / General / /

Product

triad / Anthelios / Helioblock-SX SPF40 Sunscreen Cream / SPF20 W/R Cream / US / SPF15 / HSX / study drug / Helioblock / SPF / W/R Cream / Helioblock SX SPF40 Cream / SPF20 / SPF15 W/R Cream / products / V3156 / /

Technology

Pharmacokinetics / Pharmacodynamics / /

SocialTag